XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Share-based Compensation
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
4
)
Share-Based Compensation
 
Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).
 
The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended
December 31, 2016.
The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):
 
    Three Months Ended
June 30,
  Six Months Ended
June 30,
Share-based compensation related to:   2017   2016   2017   2016
Common stock granted to the Board of Directors   $
105
    $
105
    $
105
    $
105
 
Common stock granted to the Chief Executive Officer    
100
     
100
     
200
     
200
 
Stock options granted to directors and employees    
117
     
141
     
126
     
177
 
Restricted Stock Unit awards to employees    
105
     
95
     
205
     
160
 
Total share-based compensation   $
427
    $
441
    $
636
    $
642
 
 
The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately
$199,000
and
$103,000,
respectively, for the
three
-month periods ended
June 30, 2017
and
2016,
and approximately
$336,000
and
$161,000,
respectively, for the
six
-month periods ended
June 30, 2017
and
2016
.
 
The following is a summary of stock option activity under all plans for the
three
-month period ended
June 30, 2017
:
 
 
 
Shares Under
Options
 
Weighted
Average
Exercise Price
 (per share)
 
Weighted
Average
Remaining
Contractual
Life
(in years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at December 31, 2016    
232,578
    $
16.53
     
 
     
 
 
Granted    
12,336
     
27.05
     
 
     
 
 
Exercised    
(33,196
)    
26.45
     
 
     
 
 
Expired    
(3,750
)    
18.85
     
 
     
 
 
Outstanding at June 30, 2017    
207,968
    $
17.41
     
3.75
    $
2,201
 
Exercisable at June 30, 2017    
201,718
    $
17.21
     
3.80
    $
2,177
 
Vested and expected to vest at June 30, 2017    
207,968
    $
17.41
     
3.75
    $
2,201
 
 
On
June 6, 2017,
the Company granted options to its directors for the purchase of
12,336
shares of common stock at that day’s closing price of
$27.05.
The compensation expense related to these grants was determined as the fair value of the options using the Black Scholes option pricing model based on the following assumptions:
 
Expected volatility
29.1%
Expected dividends
None
Risk-free interest rate
1.84%
Exercise price
$27.05
Expected term (in years)
5.8
Weighted-average grand date fair value
$8.51
 
The stock volatility for each grant is determined based on a review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term, and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected term is estimated based on historical option exercise activity.
 
During the
six
-month periods ended
June 30, 2017
and
2016
, the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately
$391,000
and
$518,000,
respectively, and the total amount of consideration received by the Company from the exercised options was approximately
$487,000
and
$449,000,
respectively. At its discretion, the Company allows option holders to surrender previously owned common stock in lieu of paying the exercise price and withholding taxes. During the
six
-month period ended
June 30, 2017
there were
6,511
shares
surrendered at an average market price of
$26.45.
During the
six
-month period ended
June 30, 2016
there were
no
shares surrendered for this purpose.
 
On
February 2
1,
2017,
the Company’s Compensation Committee approved the award of
$400,000,
payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the
2003
Incentive Plan. The shares will be issued in
December, 2017.
 
The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the
six
-month period ended
June 30, 2017:
 
    Restricted
Stock Units
  Weighted Average
Award Date
Fair Value
Unvested at December 31, 2016    
46,558
    $
20.05
 
Awarded    
30,360
     
24.70
 
Shares vested    
(13,419
)    
23.54
 
Unvested at June 30, 2017    
63,499
    $
21.23
 
 
At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax, and the remaining amount is converted into the equivalent number of common shares. During the
six
-month periods ended
June 30, 2017
and
2016,
4,377
and
3,889
shares were surrendered at an average market price of
$24.50
and
$22.82,
respectively.
 
As of
June 30, 2017,
the Company had approximately
$900,000
of unrecognized compensation expense, which is expected to be recognized over a period of
3.75
years
.